177 related articles for article (PubMed ID: 28629477)
1. Identification of EGF-NF-κB-FOXC1 signaling axis in basal-like breast cancer.
Chung S; Jin Y; Han B; Qu Y; Gao B; Giuliano AE; Cui X
Cell Commun Signal; 2017 Jun; 15(1):22. PubMed ID: 28629477
[TBL] [Abstract][Full Text] [Related]
2. FOXC1 regulates the functions of human basal-like breast cancer cells by activating NF-κB signaling.
Wang J; Ray PS; Sim MS; Zhou XZ; Lu KP; Lee AV; Lin X; Bagaria SP; Giuliano AE; Cui X
Oncogene; 2012 Nov; 31(45):4798-802. PubMed ID: 22249250
[TBL] [Abstract][Full Text] [Related]
3. FOXC1 is a critical mediator of EGFR function in human basal-like breast cancer.
Jin Y; Han B; Chen J; Wiedemeyer R; Orsulic S; Bose S; Zhang X; Karlan BY; Giuliano AE; Cui Y; Cui X
Ann Surg Oncol; 2014 Dec; 21 Suppl 4(0 4):S758-66. PubMed ID: 25124473
[TBL] [Abstract][Full Text] [Related]
4. Basal-like breast cancer defined by FOXC1 expression offers superior prognostic value: a retrospective immunohistochemical study.
Ray PS; Bagaria SP; Wang J; Shamonki JM; Ye X; Sim MS; Steen S; Qu Y; Cui X; Giuliano AE
Ann Surg Oncol; 2011 Dec; 18(13):3839-47. PubMed ID: 21424368
[TBL] [Abstract][Full Text] [Related]
5. Diagnosis of Basal-Like Breast Cancer Using a FOXC1-Based Assay.
Jensen TW; Ray T; Wang J; Li X; Naritoku WY; Han B; Bellafiore F; Bagaria SP; Qu A; Cui X; Taylor CR; Ray PS
J Natl Cancer Inst; 2015 Aug; 107(8):. PubMed ID: 26041837
[TBL] [Abstract][Full Text] [Related]
6. FOXC1 identifies basal-like breast cancer in a hereditary breast cancer cohort.
Johnson J; Choi M; Dadmanesh F; Han B; Qu Y; Yu-Rice Y; Zhang X; Bagaria S; Taylor C; Giuliano AE; Amersi F; Cui X
Oncotarget; 2016 Nov; 7(46):75729-75738. PubMed ID: 27708239
[TBL] [Abstract][Full Text] [Related]
7. The role and the potential regulatory pathways of high expression of forkhead box C1 in promoting tumor growth and metastasis of basal-like breast cancer.
Zuo HD; Wu Yao W
J BUON; 2016; 21(4):818-825. PubMed ID: 27685901
[TBL] [Abstract][Full Text] [Related]
8. The potential pathway of FOXC1 high expression in regulating the proliferation, migration, cell cycle and epithelialmesenchymal transition of basal-like breast cancer and in vivo imaging.
Zuo H; Yang Q
J BUON; 2018; 23(3):720-728. PubMed ID: 30003742
[TBL] [Abstract][Full Text] [Related]
9. FOXC1 Activates Smoothened-Independent Hedgehog Signaling in Basal-like Breast Cancer.
Han B; Qu Y; Jin Y; Yu Y; Deng N; Wawrowsky K; Zhang X; Li N; Bose S; Wang Q; Sakkiah S; Abrol R; Jensen TW; Berman BP; Tanaka H; Johnson J; Gao B; Hao J; Liu Z; Buttyan R; Ray PS; Hung MC; Giuliano AE; Cui X
Cell Rep; 2015 Nov; 13(5):1046-58. PubMed ID: 26565916
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of FOXC1 as a therapeutic target for basal-like breast cancer.
Mott L; Su K; Pack DW
Cancer Gene Ther; 2018 May; 25(3-4):84-91. PubMed ID: 29511313
[TBL] [Abstract][Full Text] [Related]
11. Epidermal growth factor receptor (EGFR) is transcriptionally induced by the Y-box binding protein-1 (YB-1) and can be inhibited with Iressa in basal-like breast cancer, providing a potential target for therapy.
Stratford AL; Habibi G; Astanehe A; Jiang H; Hu K; Park E; Shadeo A; Buys TP; Lam W; Pugh T; Marra M; Nielsen TO; Klinge U; Mertens PR; Aparicio S; Dunn SE
Breast Cancer Res; 2007; 9(5):R61. PubMed ID: 17875215
[TBL] [Abstract][Full Text] [Related]
12. EGF stimulates uPAR expression and cell invasiveness through ERK, AP-1, and NF-kappaB signaling in human gastric carcinoma cells.
Baek MK; Kim MH; Jang HJ; Park JS; Chung IJ; Shin BA; Ahn BW; Jung YD
Oncol Rep; 2008 Dec; 20(6):1569-75. PubMed ID: 19020743
[TBL] [Abstract][Full Text] [Related]
13. FOXC1-induced non-canonical WNT5A-MMP7 signaling regulates invasiveness in triple-negative breast cancer.
Han B; Zhou B; Qu Y; Gao B; Xu Y; Chung S; Tanaka H; Yang W; Giuliano AE; Cui X
Oncogene; 2018 Mar; 37(10):1399-1408. PubMed ID: 29249801
[TBL] [Abstract][Full Text] [Related]
14. Transforming growth factor-beta1-mediated activation of NF-kappaB contributes to enhanced ADAM-12 expression in mammary carcinoma cells.
Ray A; Dhar S; Ray BK
Mol Cancer Res; 2010 Sep; 8(9):1261-70. PubMed ID: 20688878
[TBL] [Abstract][Full Text] [Related]
15. FOXC1 is a potential prognostic biomarker with functional significance in basal-like breast cancer.
Ray PS; Wang J; Qu Y; Sim MS; Shamonki J; Bagaria SP; Ye X; Liu B; Elashoff D; Hoon DS; Walter MA; Martens JW; Richardson AL; Giuliano AE; Cui X
Cancer Res; 2010 May; 70(10):3870-6. PubMed ID: 20406990
[TBL] [Abstract][Full Text] [Related]
16. Analysis of the epidermal growth factor receptor promoter: the effect of nuclear factor-kappaB.
Nishi H; Neta G; Nishi KH; Akers LM; Rikiyama T; Proctor KN; Murphy BA; Johnson AC
Int J Mol Med; 2003 Jan; 11(1):49-55. PubMed ID: 12469217
[TBL] [Abstract][Full Text] [Related]
17. FOXC1: an emerging marker and therapeutic target for cancer.
Han B; Bhowmick N; Qu Y; Chung S; Giuliano AE; Cui X
Oncogene; 2017 Jul; 36(28):3957-3963. PubMed ID: 28288141
[TBL] [Abstract][Full Text] [Related]
18. Epidermal growth factor-induced nuclear factor kappa B activation: A major pathway of cell-cycle progression in estrogen-receptor negative breast cancer cells.
Biswas DK; Cruz AP; Gansberger E; Pardee AB
Proc Natl Acad Sci U S A; 2000 Jul; 97(15):8542-7. PubMed ID: 10900013
[TBL] [Abstract][Full Text] [Related]
19. Forkhead box C1 promoter upstream transcript, a novel long non-coding RNA, regulates proliferation and migration in basal-like breast cancer.
Liu J; Shen L; Yao J; Li Y; Wang Y; Chen H; Geng P
Mol Med Rep; 2015 Apr; 11(4):3155-9. PubMed ID: 25516208
[TBL] [Abstract][Full Text] [Related]
20. Indole-3-carbinol-induced modulation of NF-kappaB signalling is breast cancer cell-specific and does not correlate with cell death.
Moiseeva EP; Heukers R
Breast Cancer Res Treat; 2008 Jun; 109(3):451-62. PubMed ID: 17653853
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
